fda shortage semaglutide crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many 📢 FDA has determined the

Tips for Managing Your Medication on Longer Journeys Plan your dosing schedule with your prescriber, pack at least one week's extra supply, stay well hydrated to reduce gastrointestinal side effects, and inform your travel insurer you are carrying a prescription injectable

This is the pathway most people are familiar with

Semaglutide is a once-weekly GLP-1 receptor agonist developed by Novo Nordisk and approved as Ozempic for type 2 diabetes, Wegovy for chronic weight management, and Rybelsus as an oral tablet

Check with your doctor: sometimes fatigue signals a deeper issue, like vitamin deficiency or medication adjustments needed

Common gastrointestinal side effects include: Nausea (reported in up to 44% of patients) Diarrhoea (approximately 30% of patients) Vomiting (24% of patients) Constipation (around 24% of patients) Abdominal pain (approximately 20% of patients) Dyspepsia and gastro-oesophageal reflux Flatulence and abdominal distension These effects are typically most pronounced during the initial weeks of treatment and during dose escalation